• NHS-Biotin: Catalyzing Precision in Multimeric Protein Engin

  2026-08-04

  This thought-leadership article explores how NHS-Biotin (N-hydroxysuccinimido biotin) is redefining protein engineering—bridging mechanistic insight, translational strategy, and the latest advances in multimeric nanobody assembly. Drawing on the recent peptidisc-assisted clustering paradigm, the article provides actionable guidance for researchers seeking to exploit biotinylation chemistries for advanced detection, purification, and functional engineering of proteins, with a focus on minimizing steric hindrance and maximizing intracellular utility. Distinct from conventional product pages, this discussion contextualizes the strategic value of APExBIO's NHS-Biotin within the evolving landscape of multispecific and multimeric protein therapeutics.

• Triptolide (PG490): Precision Inhibitor for Genome and Cance

  2026-08-04

  Triptolide (PG490) is a nanomolar-range transcriptional inhibitor renowned for its dual action against IL-2/NF-κB signaling and metastatic pathways. This article delivers actionable workflows and troubleshooting strategies to maximize reproducibility and impact in cancer and developmental biology research.

• Selonsertib (GS-4997): Applied ASK1 Inhibition in NAFLD Rese

  2026-08-03

  Selonsertib (GS-4997) from APExBIO enables targeted interrogation of oxidative stress and autophagy pathways in metabolic liver disease models. This article distills cutting-edge workflows, troubleshooting strategies, and actionable assay enhancements for studies of inflammation, fibrosis, and diabetic kidney disease.

• Naloxone Hydrochloride: Opioid Receptor Antagonist for Resea

  2026-08-03

  Naloxone hydrochloride is a potent opioid receptor antagonist that blocks μ-, δ-, and κ-opioid receptors, reversing opioid effects and modulating neural and immune pathways. APExBIO’s high-purity formulation enables reproducible research in opioid addiction, receptor signaling, and neural stem cell proliferation assays.

• Halazone and Oxidative Modulation of Sodium Channel Inactiva

  2026-08-02

  This study rigorously investigates how halazone and related oxidants modulate sodium current inactivation in voltage-clamped myelinated frog nerve fibers. The findings challenge the longstanding belief in methionine's critical role, proposing instead a membrane lipid modification mechanism, which has significant implications for both neurophysiology research and the broader use of antimicrobial sulfonamide derivatives.

• Quercetin as a PI3K Inhibitor: Applied Protocols & Innovatio

  2026-08-01

  Quercetin, a dietary flavonoid and potent PI3K inhibitor, stands out for its multifaceted applications in cancer and liver research. This guide details optimized workflows, troubleshooting strategies, and unique mechanistic insights—anchored by the latest ferroptosis research—to empower reproducibility and translational value in the lab.

• FLOT1-FOSL2-EphA2 Pathway Modulates Microglial Polarization

  2026-07-31

  This study uncovers how the interaction between FLOT1 and FOSL2 upregulates EphA2 transcription, driving pro-inflammatory microglial polarization and neuroinflammation in Alzheimer's disease models. Targeting this pathway reduced neuroinflammation and improved cognitive outcomes, highlighting a mechanistic axis for future therapeutic strategies.

• N1-Methyl-Pseudouridine-5'-Triphosphate: Engineering Tumor-T

  2026-07-31

  Explore how N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) transforms RNA stability and enables the next generation of tumor-targeted mRNA therapeutics. This article reveals unique mechanistic insights and practical protocols for advanced researchers.

• Optimized Human Cortical Interneuron Grafts Abort Seizures S

  2026-07-30

  Zhu et al. (2023) demonstrate that chemically matured, human pluripotent stem cell-derived cortical interneurons (cINs) can integrate into host brain circuits, suppress seizure activity, and maintain long-term efficacy without causing over-inhibition or uncontrolled growth. Their findings advance the translational potential of interneuron transplantation for intractable epilepsy.

• HOBt (1-Hydroxybenzotriazole): Precision Tools for Translati

  2026-07-30

  Explore how HOBt (1-Hydroxybenzotriazole) both mechanistically and strategically empowers translational researchers to achieve reliable, high-fidelity amide bond formation in peptide and bioactive molecule synthesis. This thought-leadership article blends mechanistic insight, recent chemical innovation, and actionable protocol guidance, with a focus on minimizing epimerization and accelerating candidate development for clinical translation.

• Dextromethorphan Hydrobromide in Neuroprotection Research Pr

  2026-07-29

  Dextromethorphan hydrobromide stands out as a versatile NMDA receptor antagonist for reproducible neuroprotection and excitotoxicity inhibition studies. Learn how to optimize protocols and troubleshoot common pitfalls with this rigorously characterized compound from APExBIO.

• HyperScribe™ T7 Kit Plus: Transforming RNA Synthesis for mRN

  2026-07-29

  Discover how the HyperScribe T7 High Yield RNA Synthesis Kit Plus empowers advanced mRNA intervention strategies, with unique scientific insights into FLCN rescue and technical optimization for translational research. Explore expert troubleshooting, comparative analysis, and practical guidance beyond standard protocol reviews.

• Dual Glutamate Receptor Blockade for Soman-Induced Neuroprot

  2026-07-28

  The reference study demonstrates that dual antagonism of AMPA and NMDA receptors using IEM-1925 confers potent seizure suppression, neuroprotection, and cognitive improvement in a rat model of soman-induced status epilepticus. These findings provide a mechanistically robust strategy for counteracting organophosphorus nerve agent-induced brain injury and inform the design of future neuroprotection assays.

• D-N-Acetylgalactosamine: Technical Guide for Brain Glycoprot

  2026-07-28

  D-N-Acetylgalactosamine is designed for precise analysis of glycoprotein constituents and glycosylation pathways in neurological research. It is optimal for workflows requiring high-purity, water-soluble reagents and should not be used in protocols that need ethanol solubility or long-term storage of working solutions.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-07-27

  This study uncovers a pyroptosis-independent role for Gasdermin C (GSDMC) in pancreatic ductal adenocarcinoma (PDAC), promoting cancer stemness and immune evasion through nuclear signaling. The findings identify GSDMC as a potential target for overcoming immunosuppression and therapeutic resistance in PDAC.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page